Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22341744

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2012 Mar
First author
Paz-Ares L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Mar;13(3):217-8. doi: 10.1016/S1470-2045(12)70082-7.
    note
    Source null
    related pmid
    22341743
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2012 Mar 06;9(4):187. doi: 10.1038/nrclinonc.2012.29.
    note
    Source null
    related pmid
    22392096
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2013 Oct;10(10):549-50. doi: 10.1038/nrclinonc.2013.152.
    note
    Source null
    related pmid
    23959270
    relationship
    Comment in

Authors and identifiers

  1. name
    Paz-Ares L
    type
    Author
  2. name
    de Marinis F
    type
    Author
  3. name
    Dediu M
    type
    Author
  4. name
    Thomas M
    type
    Author
  5. name
    Pujol JL
    type
    Author
  6. name
    Bidoli P
    type
    Author
  7. name
    Molinier O
    type
    Author
  8. name
    Sahoo TP
    type
    Author
  9. name
    Laack E
    type
    Author
  10. name
    Reck M
    type
    Author
  11. name
    Corral J
    type
    Author
  12. name
    Melemed S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Paz-Ares L
    type
    Author
  2. name
    de Marinis F
    type
    Author
  3. name
    Dediu M
    type
    Author
  4. name
    Thomas M
    type
    Author
  5. name
    Pujol JL
    type
    Author
  6. name
    Bidoli P
    type
    Author
  7. name
    Molinier O
    type
    Author
  8. name
    Sahoo TP
    type
    Author
  9. name
    Laack E
    type
    Author
  10. name
    Reck M
    type
    Author
  11. name
    Corral J
    type
    Author
  12. name
    Melemed S
    type
    Author
bibliography ids
  1. nci-bib-adb89487350e1d937ebb7d29
book metadata
content sha256
8a1112f8e47c86cf371057ecc4d0ddd9806ed7f82f13ea5cfa67b9708d280b21
document type
citation
dois
  1. 10.1016/S1470-2045(12)70063-3
electronic publication date
display
2012 Feb 16
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22341744
immutable id
pubmed:22341744@8a1112f8e47c86cf371057ecc4d0ddd9806ed7f82f13ea5cfa67b9708d280b21
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
247-55
volume
13
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Mar;13(3):217-8. doi: 10.1016/S1470-2045(12)70082-7.
    note
    Source null
    related pmid
    22341743
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2012 Mar 06;9(4):187. doi: 10.1038/nrclinonc.2012.29.
    note
    Source null
    related pmid
    22392096
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2013 Oct;10(10):549-50. doi: 10.1038/nrclinonc.2013.152.
    note
    Source null
    related pmid
    23959270
    relationship
    Comment in
outcomes validated
false
pmid
22341744
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
600b7264c4f842bd1acbfe2d9dc20018b60708907850232039a17c71de27960d
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Mar
precision
month
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22341744/
title
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.

Preserved source evidence · Not medical advice